Using rats with toxin-induced myasthenia gravis (TIMG), our group demonstrated that the A2AR-mediated facilitation of ACh release during high-frequency stimulation bursts is significantly impaired due to insufficient ADO outflow from myasthenic skeletal muscle fibres. The gene discussed is ADO; the disease is myasthenia gravis.